NCT06894602 Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
| NCT ID | NCT06894602 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Brest |
| Condition | Giant Cell Arteritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-08-05 |
| Primary Completion | 2028-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-08-05 with a primary completion date of 2028-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Ultrasound evaluation of the temporal and axillary arteries is currently well recognized in the field of giant cell arteritis (GCA), a disease primarily affecting medium- and large-caliber vessels. Structural ultrasound abnormalities are now well described in this pathology, but their association with relapse and clinical concordance is unknown. There is currently a follow-up score (the OGUS score) for medium- and large-caliber arteries that could also predict the clinical course of the disease.
Eligibility Criteria
Inclusion Criteria: * Major patient * Patients meeting ACR 2022 criteria for giant cell arteritis. * No opposition expressed Exclusion Criteria: * Patients unable to understand the protocol, under guardianship or curatorship. * Patients not affiliated to the French Social Security system.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06894602 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Giant Cell Arteritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06894602 currently recruiting?
Yes, NCT06894602 is actively recruiting participants. Contact the research team at sandrine.jousse-joulin@chu-brest.fr for enrollment information.
Where is the NCT06894602 trial being conducted?
This trial is being conducted at Brest, France, Quimper, France.
Who is sponsoring the NCT06894602 clinical trial?
NCT06894602 is sponsored by University Hospital, Brest. The trial plans to enroll 100 participants.